Aggressive lung cancer uses our body’s own structural scaffolding to spread. With support from The Global Lung Cancer Impact Challenge, Dr Amelia Parker is developing new antibody therapies to block cancer’s support network. 🔬Read more: https://ow.ly/rSWw50ZlprF #LungCancer

Excited to be kicking things off today for the 21st biennial Congress of the MRS. Going to be a fantastic couple of days ahead #MRS2026 #metastasis

Day 1 of the MRS Biennial Congress brought together metastasis researchers from across the globe, trainees and PIs alike. Grateful for a moment to capture this incredible scientific community. #MRS2026 #metastasis #TME

I’m thrilled and truly honored to share that I have received a @susangkomen.bsky.social Career Catalyst Research grant to support my lab’s work on breast cancer dormancy. I’m deeply grateful to my mentors and patient advocate for their continuous support in helping me reach this milestone.🎗️

Just published: Garvan researchers have mapped the world’s most detailed cellular ‘atlas’ of early-stage prostate cancer. Prof Alexander Swarbrick’s team showed that many entirely "healthy-looking" cells already harbour cancer-related DNA changes. https://ow.ly/fFAw50Yzu6O

City2Surf entries are now open! Support vital medical research by taking part with #GoGarvan. Learn more on our website: https://ow.ly/wCLb50YzwpH #City2Surf #SydneyRunning #RunForResearch #CharityRun #RunSydney #ActiveForACause #SupportResearch #SydneyEvents #MedicalResearc #City2Surf #2026

EXCITING NEWS! Registration and abstract submission for the 21st Biennial Congress of the MRS is now OPEN! Find all the information here: metastasis-research.org/2024/06/26/m...

In this episode, Dr Ankur Sharma delves into the critical insight that cancer is not just a rogue cell – it’s an entire ecosystem – and that ecosystem is the key to unlocking a new class of cures. Listen here: https://ow.ly/NWGN50Y44tv

Are you as excited as we are for the 2026 MRS Biennial Meeting? As we get closer, we’ll be highlighting speakers each week, starting today!

Incredible work demonstrating a functional role for malignant cell states in preclinical lung cancer models www.nature.com/articles/s41...

Critical role for a high-plasticity cell state in lung cancer - Nature

The high-plasticity cell state (HPCS) is a critical hub that enables reciprocal transitions between cancer cell states, and targeting the HPCS may suppress cancer progression and eradicate treatment r...

nature.com

Exciting news: Garvan’s Prof Marina Pajic has been awarded MRFF funding to lead a team undertaking two trials testing new approaches for pancreatic cancer. Read more: https://ow.ly/t4eW50Y0Z5F

An international team, co-led by Garvan's Prof Stuart Tangye, has discovered that the protein CBL is crucial for B cell development, shedding light on immune function and why some people are more prone to infections. Published today in Nature Immunology: ow.ly/gk4z50XX0Y7

Very pleased to share our new review "The Evolving Landscape of Brain Metastasis" in @cp-trendscancer.bsky.social 🧠🔬🧪 Grateful to an outstanding team of co-authors, all pioneers in the #brain #metastasis field and to @valientelab.bsky.social for co-leading this 🙏🏻 Link: www.cell.com/trends/cance...

We're looking for a Research Assistant / Senior Research Assistant to join our team. If you're interested in studying the extracellular matrix and tumour microenvironment in cancer, then get in touch. Applications will be reviewed on a rolling basis. garvan.wd3.myworkdayjobs.com/garvan_insti...

Enormous thank you to the Australian Cancer Research Foundation for awarding us a $2.5m grant to launch the ACRF MATRIX Centre – a dedicated national centre for visualising & decoding the tumour microenvironment & its impact on therapy resistance & metastasis. www.garvan.org.au/news-resourc...

Still buzzing from the fantastic ECLC virtual meeting! Thank you to all speakers and attendees for the compelling talks and discussions on metastasis research. On today, World Pancreatic Cancer Day, we honor every patient and researcher. Share your favorite paper from 2025. Starting here:

The MRS is excited to announce the awardees for the 2026 MRS Awards. Each will be presenting at the 2026 Biennial Congress in Salt Lake City, Utah, June 28 - July 1, 2026, don't miss it! 🎉Congratulations to all of our awardees! 🎉

🚀 Two weeks to go! The ECR Meeting brings together early-career scientists driving the next wave of metastasis research. ⚡ Don’t miss: 💡 Inspiring talks from rising leaders 💬 Community-led discussions 🌍 A global metastasis community 🗓️ Register by Nov 18 ➜ bit.ly/4qyxE0o Program ➜ bit.ly/4qtpVR9

2nd MRS Early Career Research Virtual Meeting | Metastasis Research

The 2025 MRS Early Career Research Virtual Meeting is a two day meeting aimed at engaging trainees and early career researchers from around the world and highlighting recent advances in metastasis research through keynote presentations, invited talks, panel discussions, and selected talks from abstracts. The meeting is organized and hosted by the Early Career Leadership Council (ECLC) of the MRS. Abstracts are being accepted for consideration for oral presentations. Abstract submission is open to graduate students, postdoctoral fellows, medical students, residents, clinical fellows, and researchers within 3 years of starting their own independent research group. Registration for this meeting is free for MRS Members!

metastasis-research.org

🚀 The program is LIVE! Our ECR Virtual Meeting brings together trainees & junior PIs pushing the frontiers of metastasis research. 💡 Inspiring talks 🤝 Community-led discussion sessions 🌍 A global Metastasis Research Society Program ➜ bit.ly/4qtpVR9 Register by Nov 18 ➜ bit.ly/4qyxE0o

🎗️ October is #BreastCancerAwarenessMonth! 💗The MRS honors survivors and researchers, including our MRS president, Dr. Alana Welm, who recently received Innovator of the Year award for advancing & sharing patient-derived breast cancer models enabling precision medicine. bit.ly/493BMiL

Excited to present at the @metastasisresearch.bsky.social webinar soon. Registration is free!

Metastatic disease affects 20-30% of early breast cancer patients. This is the frontier where we need to focus.🎯 Mac4Me’s goal is to help transform metastatic breast cancer from a typically terminal condition into a chronic or potentially curable one. #MetastaticBreastCancerAwarenessDay

Interested in establishing your own research group? Our support package for new Group Leaders includes: 🥼2 #Postdocs, a technician & 2 PhD students + lab costs 🔬Full access to core facilities 🧪Access to the MCRC #Biobank ✔️Mentorship, #grant advice & more www.cruk.manchester.ac.uk/career/new-g...

Had a fantastic time at @myueg.bsky.social week in Berlin, sharing science and meeting new colleagues/pals! Huge thanks to @metastasisresearch.bsky.social for making it possible for me to attend and share our research

Attending a meeting? Early career MRS members can apply for a bursary! metastasis-research.org/for-research... 🚨Next bursary deadline is:October 1! 🚨 🎉 Congratulations again to our latest MRS Travel Bursary winners! 🌍 Shona Ritchie (Australia) 🇺🇸 Abby Jackson (USA) 🇮🇱 Avishai Maliah (Israel)

MRS Meeting Bursaries | Metastasis Research

The Metastasis Research Society is pleased to announce the availability of up to 10 Early Career Researcher (ECR) travel scholarships annually. These scholarships aim to support young investigators in presenting their metastasis research at national and international conferences.

metastasis-research.org

As our Goodbye Flat Biology conference in Essen coincides with #WorldCancerResearchDay, what better way to mark the occasion than with a group photo? #WCRD @wcrd24sept.bsky.social

Don't miss our next webinar by Zoi Diamantopoulou on "Timing the perfect strike: Using circadian rhythms to target metastasis" - September 22, 2025 - more details and register here: metastasis-research.org/2025/09/11/z...

Pioneering trial targeting dormant residual cancer cells by L. Chodosh, A. DeMichele et al., @penncancer.bsky.social Proof-of-concept that targeting dormant RTCs in breast cancer survivors depletes MRD. NCT03032406. Congratulations for this work! www.nature.com/articles/s41...

Targeting dormant tumor cells to prevent recurrent breast cancer: a randomized phase 2 trial - Nature Medicine

A combination of mouse model data and data from a randomized phase 2 trial in patients with breast cancer in remission demonstrates feasibility, safety and a reduction in residual tumor cells followin...

nature.com

How do #metastases survive (and thrive!) in the #brain microenvironment? In our review, now online @cp-neuron.bsky.social, we discuss the recent findings on #cancerneuroscience of #brainmetastases: Learn all about how #cancer cells adapt to, and communicate with, this unique environment 🧠

Neuron@cp-neuron.bsky.social · 11mo ago

A Review by Frank Winkler & @matthiakarreman.bsky.social on how neural-cancer interactions shape metastasis and tumor evolution www.cell.com/neuron/fullt...

🚨Excited for the 2nd MRS Early Career Research Virtual Meeting on Nov 18-19, 2025! Trainees & Junior Faculty (within 3 years of starting your lab), share your work! Abstract Deadline: Sept 12, 2025. Submit here: bit.ly/47KLyp2 ❗Free registration for MRS Members! #MRS #Research #EarlyCareer